Singularity Future Technology Ltd. (SGLY): Nasdaq/NYSE listing notice — Singularity Future receives Nasdaq bid-price deficiency notice; 180-day cure period until May 18, 2026

Singularity Future Technology Ltd.

Nasdaq notice on Nov 19, 2025: common stock failed to maintain $1 minimum bid price for 30 consecutive business days.
Initial compliance period ends May 18, 2026; must have $1+ closing bid for 10 consecutive days.
If not cured, company may qualify for a second 180-day period subject to market value and other standards.
Company may consider a reverse stock split or other options to regain compliance.
Notice has no immediate impact on Nasdaq Capital Market listing.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Singularity Future Technology Ltd. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

November 19, 2025, Singularity Future Technology Ltd. (the “Company”) received a staff determination notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), informing the Company that its common stock, no par value (the “Common Stock”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) for the 30 consecutive business days prior to the date of the Notice. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasdaq Capital M

View on SEC.gov

Browse all listing & compliance notices →

Singularity Future Technology Ltd. filing history →

Source: SEC EDGAR

accession 0001213900-25-114133

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.